ReviewEndocrinology, diabetes & metabolism2026

The Gastrointestinal Safety of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials.

Ahmed W Hageen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.